This invention relates to a compound of formula (I) ##STR1## wherein R.sub.1 and R.sub.2 are each independently hydrogen, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy; and R.sub.3 is a C.sub.7 -C.sub.9 aralkyl, the phenyl nucleus of which can be mono-, di-, or trisubstituted by halogen, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy, and nontoxic, pharmaceutically acceptable salts thereof. The compounds have useful antithrombic properties.
The present invention relates to 3,4-dihydroisoquinolinium salt derivatives. More specifically, the present invention relates to 3,4-dihydroisoquinolinium salt derivatives of the following chemical formula (I).
Chronic Behavioral and Neurochemical Effects of Four Novel N-Benzyl-2-phenylethylamine Derivatives Recently Identified as “Psychoactive” in Adult Zebrafish Screens
作者:Nikita P. Ilyin、Arslan D. Nabiullin、Anna D. Kozlova、Olga V. Kupriyanova、Vadim A. Shevyrin、Tatyana Gloriozova、Dmitry Filimonov、Alexey Lagunin、David S. Galstyan、Tatiana O. Kolesnikova、Mikael S. Mor、Evgeniya V. Efimova、Vladimir Poroikov、Konstantin B. Yenkoyan、Murilo S. de Abreu、Konstantin A. Demin、Allan V. Kalueff
DOI:10.1021/acschemneuro.4c00017
日期:2024.5.15
drugs have recently emerged as potentially promising agents in psychopharmacotherapy. Complementing laboratory rodents, the zebrafish (Danio rerio) is a powerful model organism for screening neuroactive drugs, including hallucinogens. Here, we tested four novel N-benzyl-2-phenylethylamine (NBPEA) derivatives with 2,4- and 3,4-dimethoxy substitutions in the phenethylamine moiety and the −F, −Cl, and −OCF3